Servicios Personalizados
Revista
Articulo
Links relacionados
Compartir
Revista Uruguaya de Cardiología
versión On-line ISSN 1688-0420
Resumen
SOTO, ENRIQUE et al. Asociación entre hiperhomocisteinemia, cardiopatía isquémica y diabetes tipo 2. Rev.Urug.Cardiol. [online]. 2004, vol.19, n.2-3, pp.81-87. ISSN 1688-0420.
A high plasmatic level of homocysteine is considered as a risk factor to vascular disease in the general population. However, the role of hyperhomocysteinaemia in the ischaemic heart disease development is not totally elucidated. The aim of our study was to determine in fist place, if in our sample there is an association between homocysteine levels and ischaemic heart disease and subsequently to investigate a possible association of hyperhomocysteinaemia to the presence of diabetes mellitus type 2. We analyzed the information of 204 patients attending to private health centers (depending from CASMU). All patients (61,2 ± 10,8 year olds average) were diagnosed as diabetic type 2 and ischaemic heart disease according to the ADA and Task Force guides criteria respectively. We took 5-15 µmol/l homocysteine plasmatic value as normal. The patients were classified in two groups: with (CCI) and without ischaemic heart disease (SCI). We observed statistical significant differences in the distribution of homocysteine plasmatic levels between: CCI and SCI (p<0,001). We also observed an association between hyperhomocysteinaemia and CI (OR=2,66). In the other hand, non-significant statistical differences between diabetic and non diabetics patient with CI would be indicate that that hyperhomocysteinaemia and diabetes are two independent genetics factors; the diabetes condition do not alter the association between hyperhomocisteinaemia and CI.
Palabras clave : HYPERHOMOCISTEINEMIA; HOMOCYSTEINE; MYOCARDIAL ISCHEMIA; DIABETES MELLITUS TYPE II.